Hooke Bio

Hooke Bio have developed a microfluidic, high throughput, cell based, platform designed to increase drug screening rate and reduce costs for the pharma industry

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Limerick, Ireland
  • Currency EUR
  • Founded March 2014
  • Employees 4
  • Incorporation Type LLC
  • Website hookebio.com

Company Summary

Hooke Bio have developed a unique, ultrahigh-throughput, microfluidic platform for running biochemical and cellular assays up to 16 times faster and at one quarter of the cost of current technologies. This technology is protected by a number of patent applications. Hooke has a highly experienced and skilled core team and has already attracted significant funding (€1.3m subject to DD) from private and exchequer sources.

Team

  • Mark Lyons
    CEO

    Dr. Mark Lyons (D.Phil. Oxford) has worked as Team Leader at Radisens Diagnostics and Olympus Diagnostics and has lead multidisciplinary teams in successful delivery of key milestones to multinational companies as well as successive multi-million euro European Space Agency projects.

  • Finola Cliffe
    COO

    Dr. Finola Cliffe (PhD Limerick) is a Research Fellow at the Stokes Institute. Finola has been a team member of Hooke Bio since 2014, working as a senior scientist with the interdisciplinary team of scientists and engineers. She has previously held a number of industrial research positions.

  • Lisa McInerney
    Senior Biochemist

  • Suzy Madigan
    Executive PA

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free